2019
DOI: 10.3390/ijms20164047
|View full text |Cite
|
Sign up to set email alerts
|

A Novel Method for Controlled Gene Expression via Combined Bleomycin and Plasmid DNA Electrotransfer

Abstract: Electrochemotherapy is an efficient method for the local treatment of cutaneous and subcutaneous metastases, but its efficacy as a systemic treatment remains low. The application of gene electrotransfer (GET) to transfer DNA coding for immune system modulating molecules could allow for a systemic effect, but its applications are limited because of possible side effects, e.g., immune system overactivation and autoimmune response. In this paper, we present the simultaneous electrotransfer of bleomycin and plasmi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 8 publications
(3 citation statements)
references
References 59 publications
0
3
0
Order By: Relevance
“…The induction of regulatory immune cells to treat or prevent T1D is an exceptionally promising immunotherapy for T1D . Instead of infusing regulatory immune cells directly, inducing them and halting the destructions of β-cells through making use of biomaterials are more favored. In many studies, systemic administration of biomaterials can accurately induce regulatory immune cells, delete autoreactive T-cells, re-establish immune tolerance, and meanwhile maintain the function and structure of the islets. , Among the biomaterials, nanoscale materials account for the vast majority. , As one of the promising nanoscale materials, various forms of DNA nanomaterials are usually adopted in immune therapies, such as DNA nanogels, DNA nanocapsules, and DNA origami. In immunotherapy, the DNA nanomaterials themselves were unable to modulate the immune system in most cases. , The DNA nanomaterials are commonly treated as vehicles to deliver therapeutics to the body areas that other delivery systems cannot reach …”
Section: Introductionmentioning
confidence: 99%
“…The induction of regulatory immune cells to treat or prevent T1D is an exceptionally promising immunotherapy for T1D . Instead of infusing regulatory immune cells directly, inducing them and halting the destructions of β-cells through making use of biomaterials are more favored. In many studies, systemic administration of biomaterials can accurately induce regulatory immune cells, delete autoreactive T-cells, re-establish immune tolerance, and meanwhile maintain the function and structure of the islets. , Among the biomaterials, nanoscale materials account for the vast majority. , As one of the promising nanoscale materials, various forms of DNA nanomaterials are usually adopted in immune therapies, such as DNA nanogels, DNA nanocapsules, and DNA origami. In immunotherapy, the DNA nanomaterials themselves were unable to modulate the immune system in most cases. , The DNA nanomaterials are commonly treated as vehicles to deliver therapeutics to the body areas that other delivery systems cannot reach …”
Section: Introductionmentioning
confidence: 99%
“…It is also known that one bleomycin molecule can make multiple DNA lesions [ 42 ]. In our recent publication, we demonstrated that DNA degradation takes place after bleomycin electrotransfer at concentrations used in the present paper [ 43 ]. Since ECT, like radiation therapy, is a local treatment associated with local cell damage, ROS generation, DNA damage (in case of bleomycin electrotransfer), and release of DAMPs, the bystander effect following ECT seems to be very plausible ( Figure 5 ).…”
Section: Discussionmentioning
confidence: 83%
“…4), also less popular buffers from other studies focused on nucleofection are included to enable better repeatability and consolidation of knowledge (e.g., No. 3, 6–8) ( Pakhomov et al, 2014 ; Parreno et al, 2015 ; Zhou et al, 2016 ; Chopra et al, 2019 ; Gibot et al, 2020 )…”
Section: Methodsmentioning
confidence: 99%